164 related articles for article (PubMed ID: 26393664)
1. Highly efficient uptake into cisplatin-resistant cells and the isomerization upon coordinative DNA binding of anticancer tetrazolato-bridged dinuclear platinum(II) complexes.
Uemura M; Hoshiyama M; Furukawa A; Sato T; Higuchi Y; Komeda S
Metallomics; 2015 Nov; 7(11):1488-96. PubMed ID: 26393664
[TBL] [Abstract][Full Text] [Related]
2. An in vivo highly antitumor-active tetrazolato-bridged dinuclear platinum(II) complex largely circumvents in vitro cisplatin resistance: two linkage isomers yield the same product upon reaction with 9-ethylguanine but exhibit different cytotoxic profiles.
Uemura M; Suzuki T; Nishio K; Chikuma M; Komeda S
Metallomics; 2012 Jul; 4(7):686-92. PubMed ID: 22473092
[TBL] [Abstract][Full Text] [Related]
3. A novel isomerization on interaction of antitumor-active azole-bridged dinuclear platinum(II) complexes with 9-ethylguanine. Platinum(II) atom migration from N2 to N3 on 1,2,3-triazole.
Komeda S; Lutz M; Spek AL; Yamanaka Y; Sato T; Chikuma M; Reedijk J
J Am Chem Soc; 2002 May; 124(17):4738-46. PubMed ID: 11971723
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of antitumor azolato-bridged dinuclear platinum(ii) complexes with in vivo antitumor efficacy and unique in vitro cytotoxicity profiles.
Komeda S; Takayama H; Suzuki T; Odani A; Yamori T; Chikuma M
Metallomics; 2013 May; 5(5):461-8. PubMed ID: 23608770
[TBL] [Abstract][Full Text] [Related]
5. Kinetic analysis of and platinum(II) migration in the reactions of tetrazolato-bridged dinuclear platinum(II) complexes with nucleotides.
Uemura M; Komeda S
J Inorg Biochem; 2017 Dec; 177():359-367. PubMed ID: 28893417
[TBL] [Abstract][Full Text] [Related]
6. Specific Conformational Change in Giant DNA Caused by Anticancer Tetrazolato-Bridged Dinuclear Platinum(II) Complexes: Middle-Length Alkyl Substituents Exhibit Minimum Effect.
Komeda S; Yoneyama H; Uemura M; Muramatsu A; Okamoto N; Konishi H; Takahashi H; Takagi A; Fukuda W; Imanaka T; Kanbe T; Harusawa S; Yoshikawa Y; Yoshikawa K
Inorg Chem; 2017 Jan; 56(2):802-811. PubMed ID: 28045514
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and structure-activity relationships of tetrazolato-bridged dinuclear platinum(II) complexes: A small modification at tetrazole C5 markedly influences the in vivo antitumor efficacy.
Komeda S; Yoneyama H; Uemura M; Tsuchiya T; Hoshiyama M; Sakazaki T; Hiramoto K; Harusawa S
J Inorg Biochem; 2019 Mar; 192():82-86. PubMed ID: 30612029
[TBL] [Abstract][Full Text] [Related]
8. Second- and higher-order structural changes of DNA induced by antitumor-active tetrazolato-bridged dinuclear platinum(II) complexes with different types of 5-substituent.
Uemura M; Yoshikawa Y; Yoshikawa K; Sato T; Mino Y; Chikuma M; Komeda S
J Inorg Biochem; 2013 Oct; 127():169-74. PubMed ID: 23725767
[TBL] [Abstract][Full Text] [Related]
9. Highly efficient DNA compaction mediated by an in vivo antitumor-active tetrazolato-bridged dinuclear platinum(II) complex.
Yoshikawa Y; Komeda S; Uemura M; Kanbe T; Chikuma M; Yoshikawa K; Imanaka T
Inorg Chem; 2011 Nov; 50(22):11729-35. PubMed ID: 22004345
[TBL] [Abstract][Full Text] [Related]
10. Application of fluorescence microscopy for investigation of cellular distribution of dinuclear platinum anticancer drugs.
Kalayda GV; Zhang G; Abraham T; Tanke HJ; Reedijk J
J Med Chem; 2005 Aug; 48(16):5191-202. PubMed ID: 16078838
[TBL] [Abstract][Full Text] [Related]
11. Introduction of Fluorine into Antitumor-Active Dinuclear Platinum(II) Complexes Leads to Modulation of
Uemura M; Hiramoto K; Yoneyama H; Harusawa S; Komeda S
Inorg Chem; 2022 Aug; 61(31):12155-12164. PubMed ID: 35876345
[TBL] [Abstract][Full Text] [Related]
12. Intracellular uptake of an antitumor-active azole-bridged dinuclear platinum(II) complex in cisplatin-resistant tumor cells.
Kishimoto S; Yasuda M; Suzuki R; Fukushima S
Biometals; 2016 Dec; 29(6):1075-1083. PubMed ID: 27787693
[TBL] [Abstract][Full Text] [Related]
13. Comparison of cytotoxicity and cellular accumulation of polynuclear platinum complexes in L1210 murine leukemia cell lines.
Roberts JD; Peroutka J; Beggiolin G; Manzotti C; Piazzoni L; Farrell N
J Inorg Biochem; 1999 Oct; 77(1-2):47-50. PubMed ID: 10626353
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers.
Serebryanskaya TV; Yung T; Bogdanov AA; Shchebet A; Johnsen SA; Lyakhov AS; Ivashkevich LS; Ibrahimava ZA; Garbuzenco TS; Kolesnikova TS; Melnova NI; Gaponik PN; Ivashkevich OA
J Inorg Biochem; 2013 Mar; 120():44-53. PubMed ID: 23305964
[TBL] [Abstract][Full Text] [Related]
15. Chromatin folding and DNA replication inhibition mediated by a highly antitumor-active tetrazolato-bridged dinuclear platinum(II) complex.
Imai R; Komeda S; Shimura M; Tamura S; Matsuyama S; Nishimura K; Rogge R; Matsunaga A; Hiratani I; Takata H; Uemura M; Iida Y; Yoshikawa Y; Hansen JC; Yamauchi K; Kanemaki MT; Maeshima K
Sci Rep; 2016 Apr; 6():24712. PubMed ID: 27094881
[TBL] [Abstract][Full Text] [Related]
16. Cellular accumulation and cytotoxicity of macromolecular platinum complexes in cisplatin-resistant tumor cells.
Garmann D; Warnecke A; Kalayda GV; Kratz F; Jaehde U
J Control Release; 2008 Oct; 131(2):100-6. PubMed ID: 18691617
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxicity, cellular uptake and DNA binding of the novel trinuclear platinun complex BBR 3464 in sensitive and cisplatin resistant murine leukemia cells.
Di Blasi P; Bernareggi A; Beggiolin G; Piazzoni L; Menta E; Formento ML
Anticancer Res; 1998; 18(4C):3113-7. PubMed ID: 9713519
[TBL] [Abstract][Full Text] [Related]
18. Modulation of cytotoxicity and cellular pharmacology of 1,2-diaminocyclohexane platinum (IV) complexes mediated by axial and equatorial ligands.
Kido Y; Khokhar AR; al-Baker S; Siddik ZH
Cancer Res; 1993 Oct; 53(19):4567-72. PubMed ID: 8402629
[TBL] [Abstract][Full Text] [Related]
19. New isomeric azine-bridged dinuclear platinum(II) complexes circumvent cross-resistance to cisplatin.
Komeda S; Kalayda GV; Lutz M; Spek AL; Yamanaka Y; Sato T; Chikuma M; Reedijk J
J Med Chem; 2003 Mar; 46(7):1210-9. PubMed ID: 12646031
[TBL] [Abstract][Full Text] [Related]
20. Preparation of antitumor oxaliplatin/cisplatin docking dinuclear platinum complex.
Noji M; Kizu R; Takeda Y; Akiyama N; Yoshizaki I; Eriguchi M; Kidani Y
Biomed Pharmacother; 2005 Jun; 59(5):224-9. PubMed ID: 15919175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
